This announcement is a separate document:
大理药业股份有限公司2024年半年度业绩预亏公告
Announcement of Dali Pharmaceutical Co., Ltd.'s anticipated half-year performance loss for 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.